Columbia University

Technology Ventures

Featured Funding Opportunities

In support of its mission to facilitate the transfer of inventions from academic research labs to the market, CTV publicizes funding opportunities that may be relevant to Columbia inventors as they conduct research and develop new technologies. For additional lists of funding opportunities, refer to these resources:

For further assistance with grant applications, see CTV's collection of IP and Entrepreneurship Language for Grant Applications.

Upcoming Opportunities

right
Deadline: 
Friday, November 13, 2020 - 5:00pm

 

 

Emerson Collective seeks to fund collaborative clinical research focused on populations with unequal burdens of colorectal cancer (CRC) by exploring the association between molecular characteristics such as tumor mutation and clinical characteristics such as disease stage, recurrence rate, and overall survival. 

right
Deadline: 
Saturday, October 31, 2020 - 5:00pm

 

 

Cyclica is an AI-based drug discovery company that has developed a structure-based, AI-augmented in silico drug discovery platform. CAPP is an opportunity for academic investigators to apply for in-kind access to Cyclica’s drug development platforms. The program offers two types of awards: 

Ligand Design Award: to generate novel compounds for your target of interest

right
Deadline: 
Friday, November 20, 2020 - 5:00pm

Are you interested in bringing your life science innovations to life? The Columbia Life Science Accelerator programs help translate cutting-edge faculty-led university research out of the lab through project funding, education, and support for interdisciplinary teams working to advance innovative ideas with the potential to positively impact health outcomes.

The 2020-2021 cycle focuses on:

Therapeutics/Drug Development

right
Deadline: 
Thursday, December 31, 2020 - 3:15pm
Click here for a list of of COVID-19 Funding Opportunities compiled by Columbia Research.
right
Deadline: 
Thursday, December 31, 2020 - 5:00pm

 

 

 

Past Funding Opportunities

right
Deadline: 
Monday, July 27, 2020 - 5:00pm

Columbia University, New York University, and Takeda Pharmaceuticals have formed a collaborative research alliance to initiate and advance gastroenterology (GI) research programs with high potential to impact the development of new therapeutics for patients with GI disorders. Takeda is a global, value-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines.

right
Deadline: 
Monday, September 21, 2020 - 5:00pm

Pfizer’s Centers for Therapeutic Innovation, or CTI, is a unique joint drug discovery model focused on collaborating with leading academic medical centers to translate and transform concepts into breakthroughs that change patients’ lives.

right
Deadline: 
Monday, May 18, 2020 - 5:00pm
Overview:
The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute® (HDI) have partnered to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias.
right
Deadline: 
Friday, April 10, 2020 - 11:00am
Overview:
Harrington Discovery Institute® (HDI) is committed to supporting the work of physician-scientists. The flagship Harrington Scholar-Innovator program recognizes physician-scientists whose research has the potential to advance the standard of care. The two-year grant includes $100,000 guaranteed, with the potential to qualify for up to $700,000.
right
Deadline: 
Thursday, April 9, 2020 - 5:00pm
To apply, or to check whether your project would be eligible, please speak with your CTV Licensing Officer first, then visit hudsonheightsinnovations.com to complete and submit the Letter-of-Intent (LOI). If you do not have a CTV Licensing Officer, please email techventures@columbia.edu to be assigned one.
right
Deadline: 
Monday, April 27, 2020 - 5:00pm

Interested investigators can sign up to attend office hours on March 3 with CSL and CTV here

 
CSL Behring is a leading global biotechnology company that develops and delivers innovative biotherapies to help people living with life threatening medical conditions live full lives.
right
Deadline: 
Sunday, November 24, 2019 - 5:00pm
Calling all inventors, entrepreneurs, and startups with a fast moving consumer good to submit their product to the 2nd annual P&G Ventures Innovation Challenge at CES 2020.
 
By entering you have the chance to win an all-expense paid trip to CES 2020 and pitch to a panel of judges including P&G Ventures leadership team live on the P&G Life Lab Stage. The ultimate winner will win $70,000, become a finalist in Techstars Accelerator Program, and receive 2 tickets to EV Strategic Growth Forum.
right
Deadline: 
Monday, December 9, 2019 - 5:00pm
The AIMS Awards were created to harness AI technology to facilitate and encourage drug discovery for all scientists.

Pages